These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 9453018

  • 1. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR.
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quantitative studies of human urinary excretion of uropontin.
    Min W, Shiraga H, Chalko C, Goldfarb S, Krishna GG, Hoyer JR.
    Kidney Int; 1998 Jan; 53(1):189-93. PubMed ID: 9453017
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B, Nakagawa Y, Coe FL.
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [Abstract] [Full Text] [Related]

  • 5. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F, Lacour B, Daudon M.
    Nephrologie; 1996 Jul; 17(3):157-62. PubMed ID: 9064564
    [Abstract] [Full Text] [Related]

  • 6. [Role of uropontin in calcium oxalate lithogenesis].
    Paulhac P, Desgrandchamps F, Dumas JP, Teillac P, Le Duc A, Colombeau P.
    Prog Urol; 2002 Feb; 12(1):114-7. PubMed ID: 11980003
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
    Hoyer JR, Asplin JR, Otvos L.
    Kidney Int; 2001 Jul; 60(1):77-82. PubMed ID: 11422738
    [Abstract] [Full Text] [Related]

  • 8. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F, Khan SR.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [Abstract] [Full Text] [Related]

  • 9. Exploring calcium oxalate crystallization: a constant composition approach.
    Kolbach-Mandel AM, Kleinman JG, Wesson JA.
    Urolithiasis; 2015 Oct; 43(5):397-409. PubMed ID: 26016572
    [Abstract] [Full Text] [Related]

  • 10. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
    Thongboonkerd V, Chutipongtanate S, Semangoen T, Malasit P.
    J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
    [Abstract] [Full Text] [Related]

  • 11. Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
    Lieske JC, Hammes MS, Toback FG.
    Scanning Microsc; 1996 Apr; 10(2):519-33; discussion 533-4. PubMed ID: 9813629
    [Abstract] [Full Text] [Related]

  • 12. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B, Jordi S, Zipperle L, Ettinger E, Giovanoli R.
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [Abstract] [Full Text] [Related]

  • 13. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL, Chauvet MC, Grover PK.
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [Abstract] [Full Text] [Related]

  • 14. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis.
    Hess B, Nakagawa Y, Parks JH, Coe FL.
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F569-78. PubMed ID: 2012207
    [Abstract] [Full Text] [Related]

  • 15. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M, Mulinari RA, Nakagawa Y.
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [Abstract] [Full Text] [Related]

  • 16. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
    Noonin C, Peerapen P, Yoodee S, Kapincharanon C, Kanlaya R, Thongboonkerd V.
    Chem Biol Interact; 2022 Apr 25; 357():109879. PubMed ID: 35263610
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.